| Financial Year |
March 31 2023 |
| Monetary Funds |
713,403,621.26 |
| Held-for-trading Financial Assets |
120,000,000.00 |
| Notes Receivable |
140,709.59 |
| Accounts Receivable |
358,613,423.29 |
| Advances to Suppliers |
3,745,832.31 |
| Other Receivables |
7,077,821.89 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
172,327,363.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,918,248.23 |
| Total Current Assets |
1,417,603,413.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
173,033,748.12 |
| Fixed Assetes |
386,613,259.61 |
| Under-construction Projects |
27,729,318.90 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
71,844,167.06 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,067,870.08 |
| Deferred Income Tax Assets |
1,817,139.11 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
665,605,502.88 |
| Total Assets |
2,083,208,916.22 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
42,415,658.60 |
| Accounts Payable |
93,301,122.72 |
| Accounts Received In Advance |
645,130.21 |
| Employee Compensation Payable |
7,899,687.03 |
| Taxes Payable |
9,984,250.80 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,220,174.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
274,989.63 |
| Sub-Total of Current Liabilities |
159,856,318.13 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,789,175.24 |
| Deferred Income Tax Liabilities |
18,506,624.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
46,347,271.17 |
| Total Liabilities |
206,203,589.30 |
| Paid-In Capital(Or Share Stock) |
136,266,760.00 |
| Capital Surplus |
1,037,528,563.83 |
| Surplus Reserve |
77,643,444.26 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
626,566,558.83 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,877,005,326.92 |
| Owner's Equity（Stockholder's Equity） |
1,877,005,326.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,083,208,916.22 |
